Keyphrases
Direct Oral Anticoagulants
100%
Meta-analysis
59%
Systematic Meta-analysis
59%
Atrial Fibrillation
34%
Network Meta-analysis
33%
Confidence Interval
29%
Drug Levels
28%
Apixaban
20%
Rivaroxaban
20%
Major Bleeding
19%
Odds Ratio
17%
Subtherapeutic Concentrations
17%
Calcium Channel Blockers
16%
Oral Anticoagulant Drugs
16%
Reporting System
16%
Adverse Event Reporting
16%
System Database
16%
Retrospective Cohort Study
16%
Enzyme-inducing Anti-seizure Medication
16%
Nested Case-control Study
16%
Randomized Controlled Trial
16%
Adverse Events
15%
Meta-regression
13%
Bleeding Risk
13%
Statins
13%
Regression Analysis
13%
Antiseizure Medication
12%
Anticoagulants
12%
Clopidogrel
11%
Expected Range
11%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
73%
Anticoagulant Agent
42%
Atrial Fibrillation
34%
Disease
30%
Bleeding
25%
Adverse Event
25%
Rivaroxaban
24%
Apixaban
20%
Cohort Study
18%
Case-Control Study
17%
Lung Embolism
16%
Coronavirinae
16%
Calcium Channel Blocker
16%
Randomized Controlled Trial
16%
Brain Hemorrhage
15%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
13%
Clopidogrel
13%
Congestive Heart Failure
12%
Messenger RNA
10%
Observational Study
10%
Medicine and Dentistry
Systematic Review
67%
Meta-Analysis
53%
Direct Oral Anticoagulant
33%
Meta-Regression
22%
Drug Therapy
21%
Atrial Fibrillation
17%
Antithrombotic
16%
Network Meta-Analysis
16%
Retrospective Cohort Study
16%
Anticoagulation
11%
Odds Ratio
10%
Bleeding
10%
